Has Michael Ditkoff, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,996 in general payments to Michael Ditkoff, MD across 180 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Ditkoff, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Ditkoff, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Ditkoff, MD

Otolaryngology · Manhasset, NYNPI 1235179995

Payments from drug & device makers

$4,996in general payments, 2019–2025

Across 180 payments — averaging $27.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$1K
GSK$1K
Optinose US, Inc.$523
Regeneron Healthcare Solutions, Inc.$300
Takeda Pharmaceuticals U.S.A., Inc.$289
Aerin Medical Inc.$258
plus $1K from 23 others

What the payments were for

Food & beverage$4,90898%
Education$882%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	36	$1,163
GSK	43	$1,075
Optinose US, Inc.	19	$523
Regeneron Healthcare Solutions, Inc.	12	$300
Takeda Pharmaceuticals U.S.A., Inc.	15	$289
Aerin Medical Inc.	7	$258
Neurent Medical Limited	2	$152
Stryker	4	$138
Hikma Pharmaceuticals USA	7	$126
Arrinex, Inc.	1	$115
Biotissue Holdings Inc.	1	$100
Medtronic	3	$99
ARS Pharmaceuticals Operations, Inc.	4	$91
CSL Behring	2	$85
Acclarent, Inc	3	$59
Amgen	2	$55
Intersect ENT, Inc.	2	$48
Inspire Medical Systems, Inc.	2	$46
Merck	2	$37
Aytu Biopharma, Inc.	2	$37
Phathom Pharmaceuticals, Inc.	2	$36
Smith+Nephew	2	$34
Grifols USA, LLC	1	$24
Pfizer	1	$23
Novartis	1	$20
Alk-abello, Inc	1	$18
Cumberland Pharmaceuticals, Inc.	1	$16
Oyster Point Pharma, Inc.	1	$15
Kaleo, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,996 in reported general payments places this provider in the 80th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York →

Medicare billing

Part B allowed, 2024

$330,472

Medicare patients

840

Services billed

2,596

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	252	$5,260
Azelastine Hcl	75	$1,915
Fluticasone Propionate	112	$1,690
Omeprazole	98	$875
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort	13	$470
Ofloxacin	25	$441
Famotidine	57	$360
Cefdinir	14	$322
Levocetirizine Dihydrochloride	14	$301
Montelukast Sodium	55	$218
Meclizine Hcl	22	$196
Mupirocin	23	$193
CefuroximeCefuroxime Axetil	12	$146
Mometasone Furoate	14	$145
Methylprednisolone	23	$143

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Manhasset

Robert KellmanSyracuse$2.5M
Anthony DelsignoreNew York$966K
Roheen RaithathaNew York$882K
Dennis KrausNew York$524K
Ashutosh KackerNew York$387K
Lawrence LustigNew York$383K
Brett MilesNew York$368K
Alfred Marc IloretaNew York$342K
Nora PerkinsAlbany$315K
Gavin SetzenAlbany$299K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →